Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a child or adult who has a rare disease where the biological cause or how it works in the body is not fully known or understood.
- You are already registered in the BaMaRa database, which is the French national database for people with rare diseases.
- You are covered by the French social security (health insurance) system.
- You (or your legal guardian, if applicable) have signed a consent form agreeing to take part.
- You are the parent of a child or adult with a rare disease that is not fully understood, you are registered in the BaMaRa database, you are covered by French social security, and you have signed a consent form for yourself.
- You are the brother or sister of someone with a rare disease that is not fully understood, you are registered in the BaMaRa database, you are covered by French social security, and you or your legal guardian have signed a consent form.
Who may not be able to join:
- You do not have a good enough understanding of the French language to take part.
- You are currently under a legal or administrative measure that restricts your freedom (confirm with trial site).
- You are currently receiving involuntary or forced psychiatric care.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Estelle COLIN, MD-PhD, escolin@chu-angers.fr
Phone: 02.41.35.34.70
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of at least 80 new genes implicated in rare diseases via high-throughput sequencing technics and through functional studies.; Collecting biological samples to build up a biobank; Candidat gene validation through functional studies.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.